Article(id=1330225723484255181, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225632362999820, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2022.06.007, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1644854400000, receivedDateStr=2022-02-15, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795080126877, onlineDateStr=2026-11-19, pubDate=1654790400000, pubDateStr=2022-06-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795080126877, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795080126877, creator=13701087609, updateTime=1795080126877, updator=13701087609, issue=Issue{id=1330225632362999820, tenantId=1146029695717560320, journalId=1319690329412173987, year='2022', volume='43', issue='6', pageStart='643', pageEnd='810', issueExtLink='null', onlineDate='null', pubDate='1654790400000', pubDateStr='2022-06-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795080105152, creator='13701087609', updateTime=1795084738205, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330245065345184449, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225632362999820, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330245065345184450, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225632362999820, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=689, endPage=693, ext={EN=ArticleExt(id=1330225723689776078, articleId=1330225723484255181, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Time horizon of pharmacoeconomic evaluation to support the adjustment of national reimbursement drug list, columnId=1325221107665612978, journalTitle=World Clinical Drug, columnName=Topic, runingTitle=null, highlight=null, articleAbstract=

Time horizon has a direct impact on the "incremental cost-effectiveness ratio" of pharmacoeconomic evaluation results. There are no clear requirements or explanations on the setting method of time horizon in the guidance documents related to pharmacoeconomic evaluation, such as national health policies and pharmacoeconomic evaluation guidelines. Based on the official specifications of typical countries and regions, the paper analyzed the characteristics and descriptions of different official specifications on time horizon. It was suggested that China (except Hong Kong, Macao and Taiwan) should pay attention to the detailed explanation of the determinants of the selection of time horizon and the rationality of the selection results when conducting pharmacoeconomic evaluation based on official specifications, and present the uncertainty analysis of time horizon and the corresponding results in the submission guidelines.

, authors=Meng ZHANG, Lei CHEN, Xiaoyu XI*, authorsList=Meng ZHANG, Lei CHEN, Xiaoyu XI, authorCompany=null, correspAuthors=Xiaoyu XI, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330225724042097616, articleId=1330225723484255181, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=用于支持医保目录调整的药物经济学评价研究时限限定, columnId=1325221107824996532, journalTitle=世界临床药物, columnName=医药专论, runingTitle=null, highlight=null, articleAbstract=

研究时限对药物经济学评价结果的“增量成本-效果比”有着直接影响。各国卫生政策、药物经济学评价指南等与药物经济学评价相关的指导文件均未对研究时限的设置方法作出明确的要求或解释,该文基于典型国家(地区)的官方规范,分析不同官方规范对研究时限的规定特点及描述,建议中国(除香港、澳门及台湾外)在基于官方规范进行药物经济学评价时,应注意详细解释选择研究时限的取决因素及选择结果的合理性,并在递交报告中呈现对研究时限的不确定分析及对应的结果。

, authors=张猛, 陈磊, 席晓宇*, authorsList=张猛, 陈磊, 席晓宇, authorCompany=null, correspAuthors=席晓宇, authorNote=

张猛,硕士研究生,研究方向:药物经济学与医药卫生政策。

, correspAuthorsNote=
席晓宇,研究员,博士生导师,研究方向:药物经济学与医药卫生政策。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=thyVla2HsGvMf6f0a+zSAw==, magXml=1QM9J/zxqtDmTrPjC6hdQw==, pdfUrl=null, pdf=UyAchRpp/OQudMHED1mX2w==, pdfFileSize=1700485, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=X7xwTXfpnSUWr+Kedy3nbg==, mapNumber=null, fund=null)}, authors=[Author(id=1330225725770150869, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225725908562903, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, authorId=1330225725770150869, language=EN, stringName=Meng ZHANG, firstName=Meng, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=The Research Center of National Drug Policy & Ecosystem, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225726013420504, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, authorId=1330225725770150869, language=CN, stringName=张猛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国药科大学国家药物政策与医药产业经济研究中心,江苏 南京 211198, bio={"content":"

张猛,硕士研究生,研究方向:药物经济学与医药卫生政策。

"}, bioImg=null, bioContent=

张猛,硕士研究生,研究方向:药物经济学与医药卫生政策。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225725673681873, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, xref=null, ext=[AuthorCompanyExt(id=1330225725686264786, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, companyId=1330225725673681873, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=The Research Center of National Drug Policy & Ecosystem, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1330225725694653395, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, companyId=1330225725673681873, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国药科大学国家药物政策与医药产业经济研究中心,江苏 南京 211198)])]), Author(id=1330225726143443930, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225726348964828, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, authorId=1330225726143443930, language=EN, stringName=Lei CHEN, firstName=Lei, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=The Research Center of National Drug Policy & Ecosystem, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225726458016733, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, authorId=1330225726143443930, language=CN, stringName=陈磊, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国药科大学国家药物政策与医药产业经济研究中心,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225725673681873, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, xref=null, ext=[AuthorCompanyExt(id=1330225725686264786, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, companyId=1330225725673681873, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=The Research Center of National Drug Policy & Ecosystem, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1330225725694653395, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, companyId=1330225725673681873, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国药科大学国家药物政策与医药产业经济研究中心,江苏 南京 211198)])]), Author(id=1330225726529319903, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330225726613205985, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, authorId=1330225726529319903, language=EN, stringName=Xiaoyu XI, firstName=Xiaoyu, middleName=null, lastName=XI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=The Research Center of National Drug Policy & Ecosystem, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225726671926242, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, authorId=1330225726529319903, language=CN, stringName=席晓宇, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=中国药科大学国家药物政策与医药产业经济研究中心,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225725673681873, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, xref=null, ext=[AuthorCompanyExt(id=1330225725686264786, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, companyId=1330225725673681873, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=The Research Center of National Drug Policy & Ecosystem, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1330225725694653395, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, companyId=1330225725673681873, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国药科大学国家药物政策与医药产业经济研究中心,江苏 南京 211198)])])], keywords=[Keyword(id=1330225726760006627, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, language=EN, orderNo=1, keyword=pharmacoeconomic evaluation), Keyword(id=1330225726822921188, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, language=EN, orderNo=2, keyword=time horizon), Keyword(id=1330225726881641445, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, language=EN, orderNo=3, keyword=incremental cost-effectiveness ratio), Keyword(id=1330225726936167398, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, language=CN, orderNo=1, keyword=药物经济学评价), Keyword(id=1330225726999081959, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, language=CN, orderNo=2, keyword=研究时限), Keyword(id=1330225727066190824, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, language=CN, orderNo=3, keyword=增量成本-效果比)], refs=[Reference(id=1330225727158465513, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=代展菁, 薛天祺, 向贵圆, 等. 基于价值定价的多适应证药品医保支付国际经验及启示[J]. 中国药房, 2021, 32(2): 139-145., articleTitle=null, refAbstract=null), Reference(id=1330225727280100330, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=黄泽华, 潘越, 钭江苑, 等. 药物经济学在医保决策中的应用[J]. 卫生经济研究, 2017, 3: 37-41., articleTitle=null, refAbstract=null), Reference(id=1330225727347209195, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Briggs AH. Handing uncertainty in cost-effectiveness models[J]. Pharmacoeconomics, 2000, 17(5): 479-500., articleTitle=null, refAbstract=null), Reference(id=1330225727422706668, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Sculpher MJ, Fenwick E, Claxton K. Assessing quality in decision analytic cost-effectiveness models: a suggested framework and example of application[J]. Pharmacoeconomics, 2000, 17(5): 461-467., articleTitle=null, refAbstract=null), Reference(id=1330225727489815533, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=《中国药物经济学评价指南》课题组. 中国药物经济学评价指南(2020版)[M]. 北京: 中国市场出版社, 2020., articleTitle=null, refAbstract=null), Reference(id=1330225727573701614, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Department of Economics and Public Health Assessment. Choices in methods for economic evaluation[EB/OL]. (2012-10-02) [2020-02-12]. https://www.has-sante.fr/upload/docs/application/pdf/2012-10/choices_in_methods_for_economic_evaluation.pdf., articleTitle=null, refAbstract=null), Reference(id=1330225727636616175, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Kim DD, Wilkinson CL, Pope EF, et al. The influence of time horizon on results of cost-effectiveness analyses[J]. Expert Rev Pharm Out, 2017, 17(6): 615-623., articleTitle=null, refAbstract=null), Reference(id=1330225727712113648, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Department of Health. Guidelines for preparing a submission to the Pharmaceutical Benefits Advisory Committee (version 5.0)[EB/OL]. (2016-09-01) [2020-01-21]. https://pbac.pbs.gov.au/content/information/files/pbac-guidelines-version-5.pdf., articleTitle=null, refAbstract=null), Reference(id=1330225727779222513, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Pharmaceutical Management Agency. Prescription for Pharmacoeconomic Analysis Methods for cost-utility ananlysis (version 2.2)[EB/OL]. (2015-08-01) [2020-01-21]. https://pharmac.govt.nz/assets/pfpa-2-2.pdf., articleTitle=null, refAbstract=null), Reference(id=1330225727842137074, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=National Institute Health and Care Excellence. Guide to the methods of technology appraisal 2013[EB/OL]. (2013-04-01) [2020-05-27]. https://www.nice.org.uk/process/pmg9/resources/guide-to-the-methods-of-technology-appraisal-2013-pdf-2007975843781., articleTitle=null, refAbstract=null), Reference(id=1330225727896663027, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Agency for Health Technology Assessment. Guidelines for conducting Health Technology Assessment (HTA)(version 2.1)[EB/OL]. (2009-04-01) [2011-05-19]. https://tools.ispor.org/PEguidelines/source/Poland_Guidelines-for-Conducting-HTA_English-Version.pdf., articleTitle=null, refAbstract=null), Reference(id=1330225727951188980, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Ministry of Health, Secretariat for Science, Technology and Strategic Input, et al. Methodological guidelines economic assessment guideline[EB/OL]. [2022-01-15]. https://tools.ispor.org/PEguidelines/source/Avaliacao_Economica_Brazil2014.pdf., articleTitle=null, refAbstract=null), Reference(id=1330225728014103541, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Anna Maria Galvis Gonzalez. Evaluation method guide economic health. Cuba. 2003[EB/OL]. [2022-01-21]. https://tools.ispor.org/PEguidelines/source/Methodological-Guidelines-for-Health-Economic-Evaluations-in-Cuba.pdf., articleTitle=null, refAbstract=null), Reference(id=1330225728081212406, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Teerawattananon Y, Chaikledkaew U. Thai health technology assessment guideline development[J]. J Med Assoc Thailand, 2008, 91(Suppl 2): S11-S15., articleTitle=null, refAbstract=null), Reference(id=1330225728139932663, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Fukuda T. Guideline for preparing cost-effectiveness evaluation to the central social insurance medical council[EB/OL]. [2022-01-30]. https://tools.ispor.org/PEguidelines/source/Japanese_PE_Guideline.pdf., articleTitle=null, refAbstract=null), Reference(id=1330225728202847224, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Ministry of Health Malaysia. Pharmacoeconomic guideline for Malaysia[EB/OL]. [2022-01-28]. https://tools.ispor.org/PEguidelines/source/PEguidelines-Malaysia.pdf., articleTitle=null, refAbstract=null), Reference(id=1330225728265761785, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Guidelines of Methodological Standards for Pharmacoeconomic Evaluations in Taiwan[EB/OL]. (2006-12-14) [2022-01-23]. https://tools.ispor.org/PEguidelines/source/2006_PEG_EN_2009.pdf., articleTitle=null, refAbstract=null), Reference(id=1330225728324482042, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=唐密, 赵亮, 杨燕, 等. 中国大陆与其他国家(地区)药物经济学评价指南的比较研究[J]. 中国药物经济学, 2018, 13(9): 5-10., articleTitle=null, refAbstract=null), Reference(id=1330225729922511867, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Jakubowiak AJ, Campioni M, Benedict A, et al. Cost-effectiveness of adding carfilzomib to lenalidomide and dexamethasone in relapsed multiple myeloma from a US perspective[J]. J Med Econ, 2016, 19(11): 1061-1074., articleTitle=null, refAbstract=null), Reference(id=1330225730023175164, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Brown RE, Stern S, Dhanasiri S, et al. Lenalidomide for multiple myeloma: cost-effectiveness in patients with one prior therapy in England and Wales[J]. Eur J Health Econ, 2013, 14(3): 507-514., articleTitle=null, refAbstract=null), Reference(id=1330225730102866941, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Pelligra CG, Parikh K, Guo S, et al. Cost-effectiveness of pomalidomide, carfilzomib, and daratumumab for the treatment of patients with heavily pretreated relapsed-refractory multiple myeloma in the United States[J]. Clin Ther, 2017, 39(10): 1986-2005., articleTitle=null, refAbstract=null), Reference(id=1330225730245473278, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Haacker M, Hallett TB, Atun R. On time horizons in health economic evaluations[J]. Health Policy Plan, 2020, 35(9): 1237-1243., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1330225725673681873, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, xref=null, ext=[AuthorCompanyExt(id=1330225725686264786, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, companyId=1330225725673681873, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=The Research Center of National Drug Policy & Ecosystem, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1330225725694653395, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, companyId=1330225725673681873, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国药科大学国家药物政策与医药产业经济研究中心,江苏 南京 211198)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.06.007, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.06.007, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2022.06.007, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2022.06.007, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1654790400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
用于支持医保目录调整的药物经济学评价研究时限限定
张猛 , 陈磊 , 席晓宇 *
世界临床药物 | 医药专论 2022,43(6): 689-693
收起
收藏切换
世界临床药物 |医药专论 2022 , 43 (6) : 689 -693
用于支持医保目录调整的药物经济学评价研究时限限定
全屏
[Author(id=1330225725770150869, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225725908562903, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, authorId=1330225725770150869, language=EN, stringName=Meng ZHANG, firstName=Meng, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=The Research Center of National Drug Policy & Ecosystem, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225726013420504, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, authorId=1330225725770150869, language=CN, stringName=张猛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国药科大学国家药物政策与医药产业经济研究中心,江苏 南京 211198, bio={"content":"

张猛,硕士研究生,研究方向:药物经济学与医药卫生政策。

"}, bioImg=null, bioContent=

张猛,硕士研究生,研究方向:药物经济学与医药卫生政策。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225725673681873, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, xref=null, ext=[AuthorCompanyExt(id=1330225725686264786, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, companyId=1330225725673681873, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=The Research Center of National Drug Policy & Ecosystem, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1330225725694653395, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, companyId=1330225725673681873, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国药科大学国家药物政策与医药产业经济研究中心,江苏 南京 211198)])]), Author(id=1330225726143443930, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225726348964828, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, authorId=1330225726143443930, language=EN, stringName=Lei CHEN, firstName=Lei, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=The Research Center of National Drug Policy & Ecosystem, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225726458016733, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, authorId=1330225726143443930, language=CN, stringName=陈磊, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国药科大学国家药物政策与医药产业经济研究中心,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225725673681873, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, xref=null, ext=[AuthorCompanyExt(id=1330225725686264786, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, companyId=1330225725673681873, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=The Research Center of National Drug Policy & Ecosystem, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1330225725694653395, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, companyId=1330225725673681873, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国药科大学国家药物政策与医药产业经济研究中心,江苏 南京 211198)])]), Author(id=1330225726529319903, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330225726613205985, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, authorId=1330225726529319903, language=EN, stringName=Xiaoyu XI, firstName=Xiaoyu, middleName=null, lastName=XI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=The Research Center of National Drug Policy & Ecosystem, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225726671926242, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, authorId=1330225726529319903, language=CN, stringName=席晓宇, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=中国药科大学国家药物政策与医药产业经济研究中心,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225725673681873, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, xref=null, ext=[AuthorCompanyExt(id=1330225725686264786, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, companyId=1330225725673681873, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=The Research Center of National Drug Policy & Ecosystem, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1330225725694653395, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225723484255181, companyId=1330225725673681873, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国药科大学国家药物政策与医药产业经济研究中心,江苏 南京 211198)])])]
张猛, 陈磊, 席晓宇*
作者信息
  • 中国药科大学国家药物政策与医药产业经济研究中心,江苏 南京 211198
通讯作者:
席晓宇,研究员,博士生导师,研究方向:药物经济学与医药卫生政策。
作者简介:

张猛,硕士研究生,研究方向:药物经济学与医药卫生政策。

Time horizon of pharmacoeconomic evaluation to support the adjustment of national reimbursement drug list
Meng ZHANG, Lei CHEN, Xiaoyu XI*
Affiliations
  • The Research Center of National Drug Policy & Ecosystem, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
出版时间: 2022-06-10 doi: 10.13683/j.wph.2022.06.007
文章导航
收藏切换

研究时限对药物经济学评价结果的“增量成本-效果比”有着直接影响。各国卫生政策、药物经济学评价指南等与药物经济学评价相关的指导文件均未对研究时限的设置方法作出明确的要求或解释,该文基于典型国家(地区)的官方规范,分析不同官方规范对研究时限的规定特点及描述,建议中国(除香港、澳门及台湾外)在基于官方规范进行药物经济学评价时,应注意详细解释选择研究时限的取决因素及选择结果的合理性,并在递交报告中呈现对研究时限的不确定分析及对应的结果。

药物经济学评价  /  研究时限  /  增量成本-效果比

Time horizon has a direct impact on the "incremental cost-effectiveness ratio" of pharmacoeconomic evaluation results. There are no clear requirements or explanations on the setting method of time horizon in the guidance documents related to pharmacoeconomic evaluation, such as national health policies and pharmacoeconomic evaluation guidelines. Based on the official specifications of typical countries and regions, the paper analyzed the characteristics and descriptions of different official specifications on time horizon. It was suggested that China (except Hong Kong, Macao and Taiwan) should pay attention to the detailed explanation of the determinants of the selection of time horizon and the rationality of the selection results when conducting pharmacoeconomic evaluation based on official specifications, and present the uncertainty analysis of time horizon and the corresponding results in the submission guidelines.

pharmacoeconomic evaluation  /  time horizon  /  incremental cost-effectiveness ratio
张猛, 陈磊, 席晓宇. 用于支持医保目录调整的药物经济学评价研究时限限定. 世界临床药物, 2022 , 43 (6) : 689 -693 . DOI: 10.13683/j.wph.2022.06.007
Meng ZHANG, Lei CHEN, Xiaoyu XI. Time horizon of pharmacoeconomic evaluation to support the adjustment of national reimbursement drug list[J]. World Clinical Drug, 2022 , 43 (6) : 689 -693 . DOI: 10.13683/j.wph.2022.06.007

参考文献 引证文献
排序方式:
[1]
代展菁, 薛天祺, 向贵圆, 等. 基于价值定价的多适应证药品医保支付国际经验及启示[J]. 中国药房, 2021, 32(2): 139-145.
[2]
黄泽华, 潘越, 钭江苑, 等. 药物经济学在医保决策中的应用[J]. 卫生经济研究, 2017, 3: 37-41.
[3]
Briggs AH. Handing uncertainty in cost-effectiveness models[J]. Pharmacoeconomics, 2000, 17(5): 479-500.
[4]
Sculpher MJ, Fenwick E, Claxton K. Assessing quality in decision analytic cost-effectiveness models: a suggested framework and example of application[J]. Pharmacoeconomics, 2000, 17(5): 461-467.
[5]
《中国药物经济学评价指南》课题组. 中国药物经济学评价指南(2020版)[M]. 北京: 中国市场出版社, 2020.
[6]
Department of Economics and Public Health Assessment. Choices in methods for economic evaluation[EB/OL]. (2012-10-02) [2020-02-12]. https://www.has-sante.fr/upload/docs/application/pdf/2012-10/choices_in_methods_for_economic_evaluation.pdf.
[7]
Kim DD, Wilkinson CL, Pope EF, et al. The influence of time horizon on results of cost-effectiveness analyses[J]. Expert Rev Pharm Out, 2017, 17(6): 615-623.
[8]
Department of Health. Guidelines for preparing a submission to the Pharmaceutical Benefits Advisory Committee (version 5.0)[EB/OL]. (2016-09-01) [2020-01-21]. https://pbac.pbs.gov.au/content/information/files/pbac-guidelines-version-5.pdf.
[9]
Pharmaceutical Management Agency. Prescription for Pharmacoeconomic Analysis Methods for cost-utility ananlysis (version 2.2)[EB/OL]. (2015-08-01) [2020-01-21]. https://pharmac.govt.nz/assets/pfpa-2-2.pdf.
[10]
National Institute Health and Care Excellence. Guide to the methods of technology appraisal 2013[EB/OL]. (2013-04-01) [2020-05-27]. https://www.nice.org.uk/process/pmg9/resources/guide-to-the-methods-of-technology-appraisal-2013-pdf-2007975843781.
[11]
Agency for Health Technology Assessment. Guidelines for conducting Health Technology Assessment (HTA)(version 2.1)[EB/OL]. (2009-04-01) [2011-05-19]. https://tools.ispor.org/PEguidelines/source/Poland_Guidelines-for-Conducting-HTA_English-Version.pdf.
[12]
Ministry of Health, Secretariat for Science, Technology and Strategic Input, et al. Methodological guidelines economic assessment guideline[EB/OL]. [2022-01-15]. https://tools.ispor.org/PEguidelines/source/Avaliacao_Economica_Brazil2014.pdf.
[13]
Anna Maria Galvis Gonzalez. Evaluation method guide economic health. Cuba. 2003[EB/OL]. [2022-01-21]. https://tools.ispor.org/PEguidelines/source/Methodological-Guidelines-for-Health-Economic-Evaluations-in-Cuba.pdf.
[14]
Teerawattananon Y, Chaikledkaew U. Thai health technology assessment guideline development[J]. J Med Assoc Thailand, 2008, 91(Suppl 2): S11-S15.
[15]
Fukuda T. Guideline for preparing cost-effectiveness evaluation to the central social insurance medical council[EB/OL]. [2022-01-30]. https://tools.ispor.org/PEguidelines/source/Japanese_PE_Guideline.pdf.
[16]
Ministry of Health Malaysia. Pharmacoeconomic guideline for Malaysia[EB/OL]. [2022-01-28]. https://tools.ispor.org/PEguidelines/source/PEguidelines-Malaysia.pdf.
[17]
Guidelines of Methodological Standards for Pharmacoeconomic Evaluations in Taiwan[EB/OL]. (2006-12-14) [2022-01-23]. https://tools.ispor.org/PEguidelines/source/2006_PEG_EN_2009.pdf.
[18]
唐密, 赵亮, 杨燕, 等. 中国大陆与其他国家(地区)药物经济学评价指南的比较研究[J]. 中国药物经济学, 2018, 13(9): 5-10.
[19]
Jakubowiak AJ, Campioni M, Benedict A, et al. Cost-effectiveness of adding carfilzomib to lenalidomide and dexamethasone in relapsed multiple myeloma from a US perspective[J]. J Med Econ, 2016, 19(11): 1061-1074.
[20]
Brown RE, Stern S, Dhanasiri S, et al. Lenalidomide for multiple myeloma: cost-effectiveness in patients with one prior therapy in England and Wales[J]. Eur J Health Econ, 2013, 14(3): 507-514.
[21]
Pelligra CG, Parikh K, Guo S, et al. Cost-effectiveness of pomalidomide, carfilzomib, and daratumumab for the treatment of patients with heavily pretreated relapsed-refractory multiple myeloma in the United States[J]. Clin Ther, 2017, 39(10): 1986-2005.
[22]
Haacker M, Hallett TB, Atun R. On time horizons in health economic evaluations[J]. Health Policy Plan, 2020, 35(9): 1237-1243.
2022年第43卷第6期
11
4
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2022.06.007
  • 接收时间:2022-02-15
  • 首发时间:2026-11-19
  • 出版时间:2022-06-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2022-02-15
基金
作者信息
    中国药科大学国家药物政策与医药产业经济研究中心,江苏 南京 211198

通讯作者:

席晓宇,研究员,博士生导师,研究方向:药物经济学与医药卫生政策。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.06.007
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏